FDA Import Refusal 1FX-5992475-3/20002/1 — GLAXOSMITHKLINE PHARMA LIMITED
The FDA refused shipment 1FX-5992475-3/20002/1 from GLAXOSMITHKLINE PHARMA LIMITED (India) on Aug 18, 2026. The refused product falls under Drugs and Biologics — ANTI-INFLAMMATORY N.E.C.. Cited charges: 118,75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- Aug 18, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62GAJ99 ANTI-INFLAMMATORY N.E.C.
- Charges
- 118,75